From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...

The last time 96-year-old Audrey Staniland was assessed for in-home aged care funding was with a human clinician more than a decade ago. When her daughter applied for a reassessment late last year, ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Artificial intelligence (AI) is poised to reshape pharmaceutical research by addressing some of the industry's most persistent challenges: lengthy timelines, high development costs and substantial ...

Plus: OpenAI has paused some model work over safety concerns. This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of technology.

Face ID and fingerprints are convenient, but law enforcement can bypass them much more easily than a passcode. Here's why you should go back to basics to improve your privacy and security. I review ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Wall Street is betting big on, and pouring billions into, AI, as big banks jostle to remain ahead of ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...